UiPath (PATH) has been resilient in the face of potential disruption from generative AI. At this point, it is fairly clear that the company isn’t a gen AI winner, but the business is looking rather ...

With investors' artificial intelligence focus turning to agentic AI, UiPath stock could be a long-term winner.

UiPath delivered a beat-and-raise quarter and was promoted into a midcap index. Shares of automation software company UiPath ...

UiPath remains a buy, outperforming the S&P 500 with a 53.6% gain since March 2025, driven by operational turnaround. Click ...

Geoffrey Seiler has positions in GitLab, SentinelOne, and UiPath. The Motley Fool has positions in and recommends GitLab, ...

UiPath CFO and COO Ashim Gupta outlines why the company’s recent progress rests less on agentic AI re-positioning and more on ...

UiPath is dominating the robotic process automation market. Its tools can help businesses streamline their operations and cut costs. But it could face tough competition from newer generative AI ...

UiPath stock popped more than 26% on Friday, one day after the company released quarterly earnings that beat Wall Street's top- and bottom-line expectations. Stream NBC 5 for free, 24/7, wherever you ...

UiPath is moving beyond simple, rule-based bots toward "agentic automation." Partnerships are helping to drive scalability of this evolving business. UiPath’s focus on security and transparency could ...

Testing an AI agent for donor tissue screening at Evergen surfaces more than technical performance questions. The project ...